Delivery Order SPE2DB20D1004-SPE2DB21FG0S0
Award Date
9/14/21
Potential Completion Date
9/15/21
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,392.00 firm fixed price contract is for the supply of 4565433298 - Azelastine 0.1% (137 MCG) Spray, 30ML. It is not a set-aside contract. The delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.00 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, 30ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of pharmaceutical...
This federal contract award, valued at $1,245.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Azelastine 0.1% (137 MCG) spray medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This contract award is for the delivery of Azelastine 0.1% (137 mcg) spray, 30 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, and has a ceiling value of $1,415.26. The contract is structured as a Firm Fixed Price Delivery Order, with a period of performance through September 26, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a value of $1,020.85 and is for the delivery of Azelastine 0.1% (137 mcg) nasal spray in a 30 ml container. The contract was awarded on April 18, 2023, with an ultimate completion date of April 19, 2023. It is a delivery order contract with a firm fixed price pricing type. The award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,428.72 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 mcg) Spray, 30 ml, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999 through December 2025, for delivering a comprehensive range...
This federal contract award, with ID SPE2DB20D7059|SPE2DB25FPTQ2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,322.40 firm fixed price delivery order is for the supply of 4566316369 - Azelastine 0.1% (137 MCG) Spray, 30 ML. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,612.40 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product, to support military healthcare programs. The award has an ultimate completion date of May 23, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of Azelastine 0.1% (137 MCG) Nasal Spray, 30ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a firm fixed-price delivery order with a ceiling value of $3,585.39 and an ultimate completion date of December 22, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
This contract award (SPE2DB20D2104|SPE2DB22FS22R) is for the delivery of Azelastine 0.1% (137 MCG) nasal spray, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.24 and a performance period ending on March 29, 2022. The contract was not set aside for any specific business...